nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—PTGS2—thyroid cancer	0.223	1	CbGaD
Dexamethasone—NOS2—Doxorubicin—thyroid cancer	0.149	0.277	CbGbCtD
Dexamethasone—ABCG2—Vandetanib—thyroid cancer	0.0461	0.086	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—thyroid cancer	0.0355	0.0662	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—thyroid cancer	0.0355	0.0662	CbGbCtD
Dexamethasone—ABCC2—Sorafenib—thyroid cancer	0.0307	0.0574	CbGbCtD
Dexamethasone—ABCG2—Sorafenib—thyroid cancer	0.0278	0.0519	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0205	0.0383	CbGbCtD
Dexamethasone—CYP3A7—Sorafenib—thyroid cancer	0.0205	0.0383	CbGbCtD
Dexamethasone—CYP2B6—Sorafenib—thyroid cancer	0.0195	0.0365	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—thyroid cancer	0.0186	0.0348	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—thyroid cancer	0.0169	0.0315	CbGbCtD
Dexamethasone—CYP3A5—Sorafenib—thyroid cancer	0.0154	0.0287	CbGbCtD
Dexamethasone—CYP2C8—Sorafenib—thyroid cancer	0.0148	0.0276	CbGbCtD
Dexamethasone—CYP2C19—Sorafenib—thyroid cancer	0.0124	0.0232	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—thyroid cancer	0.0119	0.0221	CbGbCtD
Dexamethasone—CYP2C9—Sorafenib—thyroid cancer	0.0103	0.0193	CbGbCtD
Dexamethasone—ABCB1—Sorafenib—thyroid cancer	0.01	0.0187	CbGbCtD
Dexamethasone—CYP3A4—Vandetanib—thyroid cancer	0.00996	0.0186	CbGbCtD
Dexamethasone—CYP2D6—Sorafenib—thyroid cancer	0.00944	0.0176	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—thyroid cancer	0.00608	0.0113	CbGbCtD
Dexamethasone—CYP3A4—Sorafenib—thyroid cancer	0.006	0.0112	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—thyroid cancer	0.00573	0.0107	CbGbCtD
Dexamethasone—CYP3A4—Doxorubicin—thyroid cancer	0.00364	0.0068	CbGbCtD
Dexamethasone—ANXA1—neck—thyroid cancer	0.00158	0.0737	CbGeAlD
Dexamethasone—ANXA1—saliva-secreting gland—thyroid cancer	0.00123	0.0575	CbGeAlD
Dexamethasone—ANXA1—trachea—thyroid cancer	0.000951	0.0443	CbGeAlD
Dexamethasone—PLA2G1B—head—thyroid cancer	0.000873	0.0407	CbGeAlD
Dexamethasone—NR3C2—saliva-secreting gland—thyroid cancer	0.000798	0.0372	CbGeAlD
Dexamethasone—ANXA1—thyroid gland—thyroid cancer	0.000752	0.0351	CbGeAlD
Dexamethasone—CYP17A1—thyroid gland—thyroid cancer	0.000674	0.0314	CbGeAlD
Dexamethasone—ANXA1—head—thyroid cancer	0.000668	0.0311	CbGeAlD
Dexamethasone—NR3C2—trachea—thyroid cancer	0.000616	0.0287	CbGeAlD
Dexamethasone—CYP17A1—head—thyroid cancer	0.000598	0.0279	CbGeAlD
Dexamethasone—CYP11A1—head—thyroid cancer	0.000557	0.0259	CbGeAlD
Dexamethasone—NR3C1—neck—thyroid cancer	0.000549	0.0256	CbGeAlD
Dexamethasone—NR3C2—thyroid gland—thyroid cancer	0.000487	0.0227	CbGeAlD
Dexamethasone—ANXA1—lymph node—thyroid cancer	0.000467	0.0218	CbGeAlD
Dexamethasone—ABCG2—saliva-secreting gland—thyroid cancer	0.000465	0.0217	CbGeAlD
Dexamethasone—PGR—thyroid gland—thyroid cancer	0.000453	0.0211	CbGeAlD
Dexamethasone—NR3C2—head—thyroid cancer	0.000432	0.0201	CbGeAlD
Dexamethasone—NR3C1—saliva-secreting gland—thyroid cancer	0.000428	0.02	CbGeAlD
Dexamethasone—CYP17A1—lymph node—thyroid cancer	0.000419	0.0195	CbGeAlD
Dexamethasone—CYP19A1—thyroid gland—thyroid cancer	0.000408	0.019	CbGeAlD
Dexamethasone—Thrombocytopenia—Vandetanib—thyroid cancer	0.000403	0.00345	CcSEcCtD
Dexamethasone—PGR—head—thyroid cancer	0.000402	0.0187	CbGeAlD
Dexamethasone—Blister—Epirubicin—thyroid cancer	0.000399	0.00341	CcSEcCtD
Dexamethasone—Haemoglobin—Sorafenib—thyroid cancer	0.000393	0.00336	CcSEcCtD
Dexamethasone—Haemorrhage—Sorafenib—thyroid cancer	0.000391	0.00334	CcSEcCtD
Dexamethasone—CYP11A1—lymph node—thyroid cancer	0.00039	0.0182	CbGeAlD
Dexamethasone—Neuritis—Epirubicin—thyroid cancer	0.000386	0.00329	CcSEcCtD
Dexamethasone—CYP1B1—thyroid gland—thyroid cancer	0.000381	0.0178	CbGeAlD
Dexamethasone—Hepatomegaly—Doxorubicin—thyroid cancer	0.000376	0.00321	CcSEcCtD
Dexamethasone—Rash erythematous—Epirubicin—thyroid cancer	0.000376	0.00321	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000375	0.00321	CcSEcCtD
Dexamethasone—Fungal infection—Epirubicin—thyroid cancer	0.000373	0.00318	CcSEcCtD
Dexamethasone—Insomnia—Vandetanib—thyroid cancer	0.000373	0.00318	CcSEcCtD
Dexamethasone—SLCO1A2—head—thyroid cancer	0.000371	0.0173	CbGeAlD
Dexamethasone—Paraesthesia—Vandetanib—thyroid cancer	0.00037	0.00316	CcSEcCtD
Dexamethasone—Blister—Doxorubicin—thyroid cancer	0.000369	0.00316	CcSEcCtD
Dexamethasone—Necrosis—Epirubicin—thyroid cancer	0.000367	0.00313	CcSEcCtD
Dexamethasone—Abscess—Epirubicin—thyroid cancer	0.000364	0.00311	CcSEcCtD
Dexamethasone—Dyspepsia—Vandetanib—thyroid cancer	0.000363	0.0031	CcSEcCtD
Dexamethasone—CYP19A1—head—thyroid cancer	0.000362	0.0169	CbGeAlD
Dexamethasone—Decreased appetite—Vandetanib—thyroid cancer	0.000358	0.00306	CcSEcCtD
Dexamethasone—Neuritis—Doxorubicin—thyroid cancer	0.000357	0.00305	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000356	0.00304	CcSEcCtD
Dexamethasone—Glycosuria—Epirubicin—thyroid cancer	0.000355	0.00304	CcSEcCtD
Dexamethasone—Stinging—Epirubicin—thyroid cancer	0.000355	0.00304	CcSEcCtD
Dexamethasone—Fatigue—Vandetanib—thyroid cancer	0.000355	0.00303	CcSEcCtD
Dexamethasone—Angiopathy—Sorafenib—thyroid cancer	0.000355	0.00303	CcSEcCtD
Dexamethasone—Pain—Vandetanib—thyroid cancer	0.000352	0.00301	CcSEcCtD
Dexamethasone—Petechiae—Epirubicin—thyroid cancer	0.00035	0.00299	CcSEcCtD
Dexamethasone—Arrhythmia—Sorafenib—thyroid cancer	0.000349	0.00298	CcSEcCtD
Dexamethasone—Rash erythematous—Doxorubicin—thyroid cancer	0.000348	0.00297	CcSEcCtD
Dexamethasone—Alopecia—Sorafenib—thyroid cancer	0.000346	0.00295	CcSEcCtD
Dexamethasone—Fungal infection—Doxorubicin—thyroid cancer	0.000345	0.00295	CcSEcCtD
Dexamethasone—CYP1A1—trachea—thyroid cancer	0.000341	0.0159	CbGeAlD
Dexamethasone—Erythema—Sorafenib—thyroid cancer	0.00034	0.00291	CcSEcCtD
Dexamethasone—Necrosis—Doxorubicin—thyroid cancer	0.000339	0.0029	CcSEcCtD
Dexamethasone—CYP1B1—head—thyroid cancer	0.000338	0.0158	CbGeAlD
Dexamethasone—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000337	0.00288	CcSEcCtD
Dexamethasone—Abscess—Doxorubicin—thyroid cancer	0.000337	0.00288	CcSEcCtD
Dexamethasone—NR3C1—trachea—thyroid cancer	0.00033	0.0154	CbGeAlD
Dexamethasone—Extravasation—Epirubicin—thyroid cancer	0.00033	0.00282	CcSEcCtD
Dexamethasone—Glycosuria—Doxorubicin—thyroid cancer	0.000329	0.00281	CcSEcCtD
Dexamethasone—Stinging—Doxorubicin—thyroid cancer	0.000329	0.00281	CcSEcCtD
Dexamethasone—Amenorrhoea—Epirubicin—thyroid cancer	0.000328	0.0028	CcSEcCtD
Dexamethasone—Abdominal pain—Vandetanib—thyroid cancer	0.000326	0.00278	CcSEcCtD
Dexamethasone—Body temperature increased—Vandetanib—thyroid cancer	0.000326	0.00278	CcSEcCtD
Dexamethasone—Petechiae—Doxorubicin—thyroid cancer	0.000324	0.00277	CcSEcCtD
Dexamethasone—Arthropathy—Epirubicin—thyroid cancer	0.000317	0.0027	CcSEcCtD
Dexamethasone—Herpes simplex—Epirubicin—thyroid cancer	0.000312	0.00267	CcSEcCtD
Dexamethasone—Angioedema—Sorafenib—thyroid cancer	0.000311	0.00266	CcSEcCtD
Dexamethasone—Syncope—Sorafenib—thyroid cancer	0.000305	0.00261	CcSEcCtD
Dexamethasone—Extravasation—Doxorubicin—thyroid cancer	0.000305	0.00261	CcSEcCtD
Dexamethasone—Ulcer—Epirubicin—thyroid cancer	0.000304	0.0026	CcSEcCtD
Dexamethasone—Amenorrhoea—Doxorubicin—thyroid cancer	0.000303	0.00259	CcSEcCtD
Dexamethasone—NR3C2—lymph node—thyroid cancer	0.000303	0.0141	CbGeAlD
Dexamethasone—Loss of consciousness—Sorafenib—thyroid cancer	0.000299	0.00256	CcSEcCtD
Dexamethasone—Asthenia—Vandetanib—thyroid cancer	0.000296	0.00252	CcSEcCtD
Dexamethasone—Hypertension—Sorafenib—thyroid cancer	0.000294	0.00251	CcSEcCtD
Dexamethasone—Arthropathy—Doxorubicin—thyroid cancer	0.000293	0.0025	CcSEcCtD
Dexamethasone—Pruritus—Vandetanib—thyroid cancer	0.000291	0.00249	CcSEcCtD
Dexamethasone—Myalgia—Sorafenib—thyroid cancer	0.00029	0.00248	CcSEcCtD
Dexamethasone—Herpes simplex—Doxorubicin—thyroid cancer	0.000289	0.00247	CcSEcCtD
Dexamethasone—Hiccups—Epirubicin—thyroid cancer	0.000288	0.00246	CcSEcCtD
Dexamethasone—PTGS2—trachea—thyroid cancer	0.000286	0.0133	CbGeAlD
Dexamethasone—Dermatitis contact—Epirubicin—thyroid cancer	0.000284	0.00243	CcSEcCtD
Dexamethasone—ABCG2—thyroid gland—thyroid cancer	0.000284	0.0132	CbGeAlD
Dexamethasone—Diarrhoea—Vandetanib—thyroid cancer	0.000282	0.00241	CcSEcCtD
Dexamethasone—Ulcer—Doxorubicin—thyroid cancer	0.000282	0.00241	CcSEcCtD
Dexamethasone—PGR—lymph node—thyroid cancer	0.000281	0.0131	CbGeAlD
Dexamethasone—Anaphylactic shock—Sorafenib—thyroid cancer	0.000278	0.00237	CcSEcCtD
Dexamethasone—Infection—Sorafenib—thyroid cancer	0.000276	0.00236	CcSEcCtD
Dexamethasone—Skin exfoliation—Epirubicin—thyroid cancer	0.000275	0.00235	CcSEcCtD
Dexamethasone—Shock—Sorafenib—thyroid cancer	0.000273	0.00234	CcSEcCtD
Dexamethasone—Fluid retention—Epirubicin—thyroid cancer	0.000273	0.00233	CcSEcCtD
Dexamethasone—Nervous system disorder—Sorafenib—thyroid cancer	0.000272	0.00233	CcSEcCtD
Dexamethasone—Dizziness—Vandetanib—thyroid cancer	0.000272	0.00233	CcSEcCtD
Dexamethasone—Thrombocytopenia—Sorafenib—thyroid cancer	0.000272	0.00232	CcSEcCtD
Dexamethasone—Neuropathy—Epirubicin—thyroid cancer	0.00027	0.00231	CcSEcCtD
Dexamethasone—CYP1A1—thyroid gland—thyroid cancer	0.000269	0.0126	CbGeAlD
Dexamethasone—Hiccups—Doxorubicin—thyroid cancer	0.000266	0.00228	CcSEcCtD
Dexamethasone—Dry eye—Epirubicin—thyroid cancer	0.000266	0.00227	CcSEcCtD
Dexamethasone—Anorexia—Sorafenib—thyroid cancer	0.000265	0.00226	CcSEcCtD
Dexamethasone—Dermatitis contact—Doxorubicin—thyroid cancer	0.000263	0.00225	CcSEcCtD
Dexamethasone—Oesophagitis—Epirubicin—thyroid cancer	0.000263	0.00225	CcSEcCtD
Dexamethasone—Vomiting—Vandetanib—thyroid cancer	0.000262	0.00224	CcSEcCtD
Dexamethasone—NR3C1—thyroid gland—thyroid cancer	0.000261	0.0122	CbGeAlD
Dexamethasone—Ecchymosis—Epirubicin—thyroid cancer	0.00026	0.00222	CcSEcCtD
Dexamethasone—Rash—Vandetanib—thyroid cancer	0.00026	0.00222	CcSEcCtD
Dexamethasone—Dermatitis—Vandetanib—thyroid cancer	0.000259	0.00222	CcSEcCtD
Dexamethasone—Headache—Vandetanib—thyroid cancer	0.000258	0.0022	CcSEcCtD
Dexamethasone—Pulmonary oedema—Epirubicin—thyroid cancer	0.000256	0.00219	CcSEcCtD
Dexamethasone—Skin exfoliation—Doxorubicin—thyroid cancer	0.000254	0.00217	CcSEcCtD
Dexamethasone—CYP19A1—lymph node—thyroid cancer	0.000253	0.0118	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000253	0.00216	CcSEcCtD
Dexamethasone—Fluid retention—Doxorubicin—thyroid cancer	0.000253	0.00216	CcSEcCtD
Dexamethasone—Neuropathy—Doxorubicin—thyroid cancer	0.00025	0.00214	CcSEcCtD
Dexamethasone—Dry eye—Doxorubicin—thyroid cancer	0.000246	0.0021	CcSEcCtD
Dexamethasone—CYP2E1—thyroid gland—thyroid cancer	0.000246	0.0115	CbGeAlD
Dexamethasone—Nausea—Vandetanib—thyroid cancer	0.000245	0.00209	CcSEcCtD
Dexamethasone—Dyspepsia—Sorafenib—thyroid cancer	0.000245	0.00209	CcSEcCtD
Dexamethasone—Oesophagitis—Doxorubicin—thyroid cancer	0.000243	0.00208	CcSEcCtD
Dexamethasone—ABCC2—lymph node—thyroid cancer	0.000242	0.0113	CbGeAlD
Dexamethasone—Decreased appetite—Sorafenib—thyroid cancer	0.000242	0.00206	CcSEcCtD
Dexamethasone—Thrombophlebitis—Epirubicin—thyroid cancer	0.000241	0.00206	CcSEcCtD
Dexamethasone—Ecchymosis—Doxorubicin—thyroid cancer	0.000241	0.00206	CcSEcCtD
Dexamethasone—Diabetes mellitus—Epirubicin—thyroid cancer	0.00024	0.00205	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00024	0.00205	CcSEcCtD
Dexamethasone—Fatigue—Sorafenib—thyroid cancer	0.00024	0.00205	CcSEcCtD
Dexamethasone—CYP1A1—head—thyroid cancer	0.000239	0.0111	CbGeAlD
Dexamethasone—Pain—Sorafenib—thyroid cancer	0.000238	0.00203	CcSEcCtD
Dexamethasone—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000237	0.00203	CcSEcCtD
Dexamethasone—CYP1B1—lymph node—thyroid cancer	0.000237	0.011	CbGeAlD
Dexamethasone—CYP2B6—head—thyroid cancer	0.000232	0.0108	CbGeAlD
Dexamethasone—NR3C1—head—thyroid cancer	0.000232	0.0108	CbGeAlD
Dexamethasone—Eye pain—Epirubicin—thyroid cancer	0.000231	0.00198	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00023	0.00197	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000227	0.00194	CcSEcCtD
Dexamethasone—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000223	0.00191	CcSEcCtD
Dexamethasone—Increased appetite—Epirubicin—thyroid cancer	0.000222	0.0019	CcSEcCtD
Dexamethasone—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000222	0.0019	CcSEcCtD
Dexamethasone—Urticaria—Sorafenib—thyroid cancer	0.000221	0.00189	CcSEcCtD
Dexamethasone—Abdominal pain—Sorafenib—thyroid cancer	0.00022	0.00188	CcSEcCtD
Dexamethasone—Body temperature increased—Sorafenib—thyroid cancer	0.00022	0.00188	CcSEcCtD
Dexamethasone—Dermatitis bullous—Epirubicin—thyroid cancer	0.000219	0.00187	CcSEcCtD
Dexamethasone—CYP2E1—head—thyroid cancer	0.000218	0.0102	CbGeAlD
Dexamethasone—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000216	0.00184	CcSEcCtD
Dexamethasone—Eye pain—Doxorubicin—thyroid cancer	0.000214	0.00183	CcSEcCtD
Dexamethasone—Cardiac failure—Epirubicin—thyroid cancer	0.000214	0.00183	CcSEcCtD
Dexamethasone—Lethargy—Epirubicin—thyroid cancer	0.000213	0.00182	CcSEcCtD
Dexamethasone—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000213	0.00182	CcSEcCtD
Dexamethasone—Osteoarthritis—Epirubicin—thyroid cancer	0.000209	0.00178	CcSEcCtD
Dexamethasone—Increased appetite—Doxorubicin—thyroid cancer	0.000206	0.00176	CcSEcCtD
Dexamethasone—Affect lability—Epirubicin—thyroid cancer	0.000206	0.00176	CcSEcCtD
Dexamethasone—Migraine—Epirubicin—thyroid cancer	0.000206	0.00176	CcSEcCtD
Dexamethasone—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000202	0.00173	CcSEcCtD
Dexamethasone—PTGS2—head—thyroid cancer	0.000201	0.00935	CbGeAlD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.0002	0.00171	CcSEcCtD
Dexamethasone—Asthenia—Sorafenib—thyroid cancer	0.000199	0.0017	CcSEcCtD
Dexamethasone—Cardiac arrest—Epirubicin—thyroid cancer	0.000199	0.0017	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—thyroid cancer	0.000198	0.00169	CcSEcCtD
Dexamethasone—Mood swings—Epirubicin—thyroid cancer	0.000198	0.00169	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—thyroid cancer	0.000197	0.00169	CcSEcCtD
Dexamethasone—Pruritus—Sorafenib—thyroid cancer	0.000197	0.00168	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—thyroid cancer	0.000193	0.00165	CcSEcCtD
Dexamethasone—Dry skin—Epirubicin—thyroid cancer	0.000192	0.00164	CcSEcCtD
Dexamethasone—Migraine—Doxorubicin—thyroid cancer	0.00019	0.00163	CcSEcCtD
Dexamethasone—Affect lability—Doxorubicin—thyroid cancer	0.00019	0.00163	CcSEcCtD
Dexamethasone—Hypokalaemia—Epirubicin—thyroid cancer	0.00019	0.00162	CcSEcCtD
Dexamethasone—Diarrhoea—Sorafenib—thyroid cancer	0.00019	0.00162	CcSEcCtD
Dexamethasone—Muscular weakness—Epirubicin—thyroid cancer	0.000184	0.00157	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—thyroid cancer	0.000184	0.00157	CcSEcCtD
Dexamethasone—Dizziness—Sorafenib—thyroid cancer	0.000184	0.00157	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—thyroid cancer	0.000183	0.00156	CcSEcCtD
Dexamethasone—Dry skin—Doxorubicin—thyroid cancer	0.000177	0.00151	CcSEcCtD
Dexamethasone—ABCB1—trachea—thyroid cancer	0.000177	0.00824	CbGeAlD
Dexamethasone—Vomiting—Sorafenib—thyroid cancer	0.000177	0.00151	CcSEcCtD
Dexamethasone—ABCG2—lymph node—thyroid cancer	0.000176	0.00822	CbGeAlD
Dexamethasone—Hypokalaemia—Doxorubicin—thyroid cancer	0.000176	0.0015	CcSEcCtD
Dexamethasone—Rash—Sorafenib—thyroid cancer	0.000175	0.0015	CcSEcCtD
Dexamethasone—Dermatitis—Sorafenib—thyroid cancer	0.000175	0.0015	CcSEcCtD
Dexamethasone—Headache—Sorafenib—thyroid cancer	0.000174	0.00149	CcSEcCtD
Dexamethasone—CYP2D6—head—thyroid cancer	0.000173	0.00804	CbGeAlD
Dexamethasone—Muscular weakness—Doxorubicin—thyroid cancer	0.000171	0.00146	CcSEcCtD
Dexamethasone—CYP1A1—lymph node—thyroid cancer	0.000167	0.0078	CbGeAlD
Dexamethasone—Nausea—Sorafenib—thyroid cancer	0.000165	0.00141	CcSEcCtD
Dexamethasone—Weight increased—Epirubicin—thyroid cancer	0.000164	0.0014	CcSEcCtD
Dexamethasone—Weight decreased—Epirubicin—thyroid cancer	0.000163	0.0014	CcSEcCtD
Dexamethasone—Hyperglycaemia—Epirubicin—thyroid cancer	0.000163	0.00139	CcSEcCtD
Dexamethasone—NR3C1—lymph node—thyroid cancer	0.000162	0.00757	CbGeAlD
Dexamethasone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000158	0.00135	CcSEcCtD
Dexamethasone—Conjunctivitis—Epirubicin—thyroid cancer	0.000157	0.00134	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—thyroid cancer	0.000152	0.0013	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—thyroid cancer	0.000151	0.00129	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000151	0.00129	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—thyroid cancer	0.000147	0.00126	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000146	0.00125	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—thyroid cancer	0.000145	0.00124	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—thyroid cancer	0.000145	0.00124	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—thyroid cancer	0.000145	0.00123	CcSEcCtD
Dexamethasone—PTGS2—lymph node—thyroid cancer	0.000141	0.00655	CbGeAlD
Dexamethasone—ABCB1—thyroid gland—thyroid cancer	0.00014	0.00652	CbGeAlD
Dexamethasone—Visual impairment—Epirubicin—thyroid cancer	0.000139	0.00119	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—thyroid cancer	0.000136	0.00116	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—thyroid cancer	0.000135	0.00115	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—thyroid cancer	0.000134	0.00115	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—thyroid cancer	0.000134	0.00114	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—thyroid cancer	0.000131	0.00112	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—thyroid cancer	0.000129	0.0011	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—thyroid cancer	0.000129	0.0011	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—thyroid cancer	0.000128	0.00109	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—thyroid cancer	0.000126	0.00107	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—thyroid cancer	0.000125	0.00107	CcSEcCtD
Dexamethasone—ABCB1—head—thyroid cancer	0.000124	0.00579	CbGeAlD
Dexamethasone—Angiopathy—Doxorubicin—thyroid cancer	0.000121	0.00104	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—thyroid cancer	0.000119	0.00102	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—thyroid cancer	0.000118	0.00101	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000117	0.000997	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—thyroid cancer	0.000116	0.000995	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—thyroid cancer	0.000113	0.000969	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—thyroid cancer	0.000113	0.000966	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—thyroid cancer	0.000113	0.000964	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—thyroid cancer	0.000111	0.000945	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—thyroid cancer	0.000109	0.000931	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—thyroid cancer	0.000109	0.000928	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000108	0.000923	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—thyroid cancer	0.000107	0.000915	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—thyroid cancer	0.000107	0.000912	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—thyroid cancer	0.000106	0.000904	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—thyroid cancer	0.000105	0.000897	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—thyroid cancer	0.000105	0.000894	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—thyroid cancer	0.000104	0.000892	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000103	0.000877	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—thyroid cancer	0.000103	0.000877	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000102	0.000874	CcSEcCtD
Dexamethasone—Infection—Epirubicin—thyroid cancer	0.000102	0.000872	CcSEcCtD
Dexamethasone—Shock—Epirubicin—thyroid cancer	0.000101	0.000863	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—thyroid cancer	0.000101	0.000862	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—thyroid cancer	0.000101	0.00086	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—thyroid cancer	0.000101	0.000859	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—thyroid cancer	0.000101	0.000859	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—thyroid cancer	0.0001	0.000856	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—thyroid cancer	9.93e-05	0.000848	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—thyroid cancer	9.91e-05	0.000847	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—thyroid cancer	9.88e-05	0.000844	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—thyroid cancer	9.79e-05	0.000837	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—thyroid cancer	9.79e-05	0.000836	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—thyroid cancer	9.6e-05	0.00082	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—thyroid cancer	9.5e-05	0.000812	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—thyroid cancer	9.5e-05	0.000812	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—thyroid cancer	9.44e-05	0.000806	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	9.36e-05	0.000799	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—thyroid cancer	9.35e-05	0.000799	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—thyroid cancer	9.32e-05	0.000796	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—thyroid cancer	9.3e-05	0.000795	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—thyroid cancer	9.29e-05	0.000793	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—thyroid cancer	9.27e-05	0.000792	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—thyroid cancer	9.22e-05	0.000788	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—thyroid cancer	9.19e-05	0.000785	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—thyroid cancer	9.06e-05	0.000774	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—thyroid cancer	9.04e-05	0.000772	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—thyroid cancer	8.93e-05	0.000763	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—thyroid cancer	8.88e-05	0.000758	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—thyroid cancer	8.87e-05	0.000757	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—thyroid cancer	8.85e-05	0.000756	CcSEcCtD
Dexamethasone—Pain—Epirubicin—thyroid cancer	8.78e-05	0.00075	CcSEcCtD
Dexamethasone—ABCB1—lymph node—thyroid cancer	8.69e-05	0.00405	CbGeAlD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	8.66e-05	0.00074	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—thyroid cancer	8.59e-05	0.000734	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—thyroid cancer	8.53e-05	0.000729	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—thyroid cancer	8.46e-05	0.000723	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—thyroid cancer	8.4e-05	0.000717	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—thyroid cancer	8.36e-05	0.000715	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—thyroid cancer	8.26e-05	0.000706	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	8.2e-05	0.000701	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—thyroid cancer	8.19e-05	0.0007	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—thyroid cancer	8.16e-05	0.000697	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—thyroid cancer	8.13e-05	0.000694	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—thyroid cancer	8.12e-05	0.000694	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—thyroid cancer	8.12e-05	0.000694	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—thyroid cancer	7.83e-05	0.000669	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—thyroid cancer	7.77e-05	0.000664	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—thyroid cancer	7.55e-05	0.000645	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—thyroid cancer	7.51e-05	0.000642	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—thyroid cancer	7.51e-05	0.000642	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—thyroid cancer	7.37e-05	0.000629	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—thyroid cancer	7.27e-05	0.000621	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—thyroid cancer	7.03e-05	0.0006	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—thyroid cancer	6.82e-05	0.000582	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—thyroid cancer	6.79e-05	0.00058	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—thyroid cancer	6.72e-05	0.000574	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—thyroid cancer	6.53e-05	0.000558	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—thyroid cancer	6.5e-05	0.000555	CcSEcCtD
Dexamethasone—Rash—Epirubicin—thyroid cancer	6.47e-05	0.000553	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—thyroid cancer	6.47e-05	0.000553	CcSEcCtD
Dexamethasone—Headache—Epirubicin—thyroid cancer	6.43e-05	0.00055	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—thyroid cancer	6.28e-05	0.000537	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—thyroid cancer	6.1e-05	0.000521	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—thyroid cancer	6.04e-05	0.000516	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—thyroid cancer	5.99e-05	0.000512	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—thyroid cancer	5.99e-05	0.000511	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—thyroid cancer	5.95e-05	0.000509	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—thyroid cancer	5.64e-05	0.000482	CcSEcCtD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.06e-05	0.0002	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—TPR—thyroid cancer	2.03e-05	0.000197	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—TPR—thyroid cancer	2.01e-05	0.000195	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CDK1—thyroid cancer	2e-05	0.000194	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PRKAR1A—thyroid cancer	1.99e-05	0.000194	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.99e-05	0.000193	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PPARG—thyroid cancer	1.98e-05	0.000192	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PTGS2—thyroid cancer	1.98e-05	0.000192	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	1.98e-05	0.000192	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—HPGD—thyroid cancer	1.95e-05	0.00019	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.94e-05	0.000188	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—RXRA—thyroid cancer	1.93e-05	0.000187	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	1.92e-05	0.000186	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—KRAS—thyroid cancer	1.91e-05	0.000186	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—HPGD—thyroid cancer	1.91e-05	0.000185	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—AKT1—thyroid cancer	1.88e-05	0.000183	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.88e-05	0.000182	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TPR—thyroid cancer	1.85e-05	0.000179	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—TPR—thyroid cancer	1.84e-05	0.000179	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.84e-05	0.000179	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.82e-05	0.000177	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PTGS2—thyroid cancer	1.82e-05	0.000176	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PRKAR1A—thyroid cancer	1.82e-05	0.000176	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	1.81e-05	0.000176	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—PPARG—thyroid cancer	1.8e-05	0.000175	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—HPGD—thyroid cancer	1.8e-05	0.000175	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.8e-05	0.000174	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—HPGD—thyroid cancer	1.78e-05	0.000173	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.78e-05	0.000173	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.75e-05	0.00017	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.74e-05	0.000169	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MEN1—thyroid cancer	1.74e-05	0.000169	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—SLC5A5—thyroid cancer	1.73e-05	0.000168	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—PTEN—thyroid cancer	1.73e-05	0.000168	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—SLC5A5—thyroid cancer	1.67e-05	0.000162	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.66e-05	0.000162	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—RXRA—thyroid cancer	1.65e-05	0.00016	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—HRAS—thyroid cancer	1.62e-05	0.000158	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.62e-05	0.000158	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—RXRA—thyroid cancer	1.61e-05	0.000156	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.6e-05	0.000156	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRG1—thyroid cancer	1.6e-05	0.000156	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.59e-05	0.000154	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PTEN—thyroid cancer	1.58e-05	0.000154	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—AKT1—thyroid cancer	1.58e-05	0.000153	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.57e-05	0.000152	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.56e-05	0.000152	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PTGS2—thyroid cancer	1.56e-05	0.000151	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.55e-05	0.000151	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—TPR—thyroid cancer	1.55e-05	0.00015	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.55e-05	0.00015	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—AKT1—thyroid cancer	1.53e-05	0.000149	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CCND1—thyroid cancer	1.52e-05	0.000148	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PRKAR1A—thyroid cancer	1.52e-05	0.000148	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—SLC5A5—thyroid cancer	1.52e-05	0.000147	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PPARG—thyroid cancer	1.52e-05	0.000147	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	1.5e-05	0.000146	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—TPR—thyroid cancer	1.49e-05	0.000144	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.47e-05	0.000143	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PTEN—thyroid cancer	1.47e-05	0.000143	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	1.46e-05	0.000142	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CHST14—thyroid cancer	1.46e-05	0.000142	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—TPR—thyroid cancer	1.45e-05	0.000141	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—RXRA—thyroid cancer	1.45e-05	0.000141	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—TPR—thyroid cancer	1.45e-05	0.000141	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.45e-05	0.00014	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TERT—thyroid cancer	1.44e-05	0.00014	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—AKT1—thyroid cancer	1.43e-05	0.000139	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.43e-05	0.000139	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.43e-05	0.000139	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.41e-05	0.000137	CbGpPWpGaD
Dexamethasone—NOS2—Disease—NRAS—thyroid cancer	1.41e-05	0.000137	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—RXRA—thyroid cancer	1.4e-05	0.000136	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PPARG—thyroid cancer	1.39e-05	0.000135	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CALCA—thyroid cancer	1.38e-05	0.000134	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—SLC5A5—thyroid cancer	1.38e-05	0.000134	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.38e-05	0.000134	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HIF1A—thyroid cancer	1.38e-05	0.000134	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PPARG—thyroid cancer	1.37e-05	0.000133	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—TPR—thyroid cancer	1.37e-05	0.000133	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.36e-05	0.000132	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—PTEN—thyroid cancer	1.36e-05	0.000132	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	1.35e-05	0.000131	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NRAS—thyroid cancer	1.31e-05	0.000127	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.3e-05	0.000127	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—RXRA—thyroid cancer	1.27e-05	0.000124	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—RXRA—thyroid cancer	1.26e-05	0.000123	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—TPR—thyroid cancer	1.26e-05	0.000122	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDK1—thyroid cancer	1.25e-05	0.000121	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.24e-05	0.00012	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.23e-05	0.00012	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.22e-05	0.000119	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PPARG—thyroid cancer	1.22e-05	0.000118	CbGpPWpGaD
Dexamethasone—NOS2—Disease—KRAS—thyroid cancer	1.22e-05	0.000118	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000116	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HPGD—thyroid cancer	1.18e-05	0.000114	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—AKT1—thyroid cancer	1.17e-05	0.000114	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—RXRA—thyroid cancer	1.16e-05	0.000113	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—SLC5A5—thyroid cancer	1.16e-05	0.000112	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—BRAF—thyroid cancer	1.14e-05	0.000111	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—KRAS—thyroid cancer	1.13e-05	0.00011	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TPR—thyroid cancer	1.12e-05	0.000109	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.12e-05	0.000109	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—SLC5A5—thyroid cancer	1.11e-05	0.000108	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.1e-05	0.000107	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TPR—thyroid cancer	1.1e-05	0.000106	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.1e-05	0.000106	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTGS2—thyroid cancer	1.09e-05	0.000106	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.000106	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.09e-05	0.000106	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTGS2—thyroid cancer	1.08e-05	0.000105	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.08e-05	0.000105	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—PPARG—thyroid cancer	1.04e-05	0.000101	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000101	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HRAS—thyroid cancer	1.03e-05	0.0001	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TPR—thyroid cancer	1.03e-05	0.0001	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.03e-05	9.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TPR—thyroid cancer	1.02e-05	9.94e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.02e-05	9.87e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.02e-05	9.87e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.01e-05	9.78e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRG1—thyroid cancer	1e-05	9.75e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—thyroid cancer	1e-05	9.75e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1e-05	9.72e-05	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—AKT1—thyroid cancer	9.94e-06	9.66e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—RXRA—thyroid cancer	9.72e-06	9.44e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.62e-06	9.35e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HRAS—thyroid cancer	9.59e-06	9.32e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTGS2—thyroid cancer	9.58e-06	9.3e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—PTEN—thyroid cancer	9.51e-06	9.24e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.45e-06	9.19e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—PTEN—thyroid cancer	9.42e-06	9.15e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	9.41e-06	9.15e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—RXRA—thyroid cancer	9.34e-06	9.08e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	9.25e-06	8.99e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PPARG—thyroid cancer	9.19e-06	8.92e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—RXRA—thyroid cancer	9.15e-06	8.89e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—RXRA—thyroid cancer	9.13e-06	8.87e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	9.13e-06	8.87e-05	CbGpPWpGaD
Dexamethasone—NOS2—Disease—AKT1—thyroid cancer	9.12e-06	8.87e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TERT—thyroid cancer	9.01e-06	8.76e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PPARG—thyroid cancer	8.85e-06	8.59e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.82e-06	8.57e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—RXRA—thyroid cancer	8.63e-06	8.38e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HIF1A—thyroid cancer	8.62e-06	8.37e-05	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AKT1—thyroid cancer	8.47e-06	8.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	8.4e-06	8.16e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.39e-06	8.15e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PTEN—thyroid cancer	8.35e-06	8.11e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CCND1—thyroid cancer	8.33e-06	8.09e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC5A5—thyroid cancer	8.2e-06	7.97e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PPARG—thyroid cancer	8.05e-06	7.82e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTEN—thyroid cancer	8.04e-06	7.81e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTGS2—thyroid cancer	7.99e-06	7.77e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PPARG—thyroid cancer	7.98e-06	7.75e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—RXRA—thyroid cancer	7.91e-06	7.68e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.87e-06	7.65e-05	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AKT1—thyroid cancer	7.83e-06	7.61e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	7.73e-06	7.51e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.69e-06	7.47e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC5A5—thyroid cancer	7.66e-06	7.44e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PPARG—thyroid cancer	7.31e-06	7.1e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTGS2—thyroid cancer	7.23e-06	7.02e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	7.18e-06	6.98e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRAS—thyroid cancer	7.17e-06	6.97e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—BRAF—thyroid cancer	7.14e-06	6.93e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—thyroid cancer	7.12e-06	6.92e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—RXRA—thyroid cancer	7.06e-06	6.86e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PTEN—thyroid cancer	6.97e-06	6.77e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTGS2—thyroid cancer	6.96e-06	6.76e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—RXRA—thyroid cancer	6.89e-06	6.69e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.87e-06	6.67e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TPR—thyroid cancer	6.75e-06	6.56e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	6.64e-06	6.45e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—RXRA—thyroid cancer	6.49e-06	6.31e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—RXRA—thyroid cancer	6.44e-06	6.25e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—thyroid cancer	6.33e-06	6.15e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—thyroid cancer	6.3e-06	6.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—thyroid cancer	6.27e-06	6.1e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.26e-06	6.08e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—thyroid cancer	6.17e-06	6e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PPARG—thyroid cancer	6.14e-06	5.96e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—thyroid cancer	6.07e-06	5.9e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—thyroid cancer	5.99e-06	5.82e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PPARG—thyroid cancer	5.9e-06	5.73e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PPARG—thyroid cancer	5.78e-06	5.61e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PPARG—thyroid cancer	5.77e-06	5.6e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—thyroid cancer	5.75e-06	5.59e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—thyroid cancer	5.52e-06	5.36e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—thyroid cancer	5.49e-06	5.33e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—thyroid cancer	5.48e-06	5.33e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—thyroid cancer	5.47e-06	5.32e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PPARG—thyroid cancer	5.45e-06	5.29e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—thyroid cancer	5.43e-06	5.27e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—thyroid cancer	5.25e-06	5.1e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.05e-06	4.91e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—thyroid cancer	5.03e-06	4.88e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—thyroid cancer	5.02e-06	4.87e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PPARG—thyroid cancer	4.99e-06	4.85e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—thyroid cancer	4.81e-06	4.68e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—thyroid cancer	4.64e-06	4.51e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—thyroid cancer	4.63e-06	4.5e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—thyroid cancer	4.54e-06	4.42e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—thyroid cancer	4.54e-06	4.41e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—thyroid cancer	4.49e-06	4.36e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PPARG—thyroid cancer	4.46e-06	4.33e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PPARG—thyroid cancer	4.35e-06	4.23e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—thyroid cancer	4.29e-06	4.16e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—RXRA—thyroid cancer	4.25e-06	4.12e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—thyroid cancer	4.21e-06	4.09e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—thyroid cancer	4.12e-06	4e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PPARG—thyroid cancer	4.1e-06	3.98e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PPARG—thyroid cancer	4.06e-06	3.95e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—thyroid cancer	4.05e-06	3.93e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—thyroid cancer	4.02e-06	3.9e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—thyroid cancer	3.96e-06	3.85e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—thyroid cancer	3.96e-06	3.84e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—thyroid cancer	3.93e-06	3.82e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—thyroid cancer	3.86e-06	3.75e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—thyroid cancer	3.74e-06	3.63e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—thyroid cancer	3.63e-06	3.53e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.51e-06	3.41e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—thyroid cancer	3.5e-06	3.4e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—thyroid cancer	3.43e-06	3.33e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—thyroid cancer	3.42e-06	3.33e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—thyroid cancer	3.28e-06	3.19e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.23e-06	3.13e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.2e-06	3.11e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—thyroid cancer	3.18e-06	3.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—thyroid cancer	3.15e-06	3.06e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—thyroid cancer	3.06e-06	2.97e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—thyroid cancer	2.98e-06	2.9e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—thyroid cancer	2.9e-06	2.82e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—thyroid cancer	2.89e-06	2.81e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—thyroid cancer	2.81e-06	2.73e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—thyroid cancer	2.79e-06	2.71e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPARG—thyroid cancer	2.68e-06	2.6e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—thyroid cancer	2.43e-06	2.36e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—thyroid cancer	2.33e-06	2.27e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—thyroid cancer	2.28e-06	2.22e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—thyroid cancer	2.28e-06	2.21e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—thyroid cancer	2.15e-06	2.09e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.11e-06	2.05e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—thyroid cancer	1.97e-06	1.92e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—thyroid cancer	1.84e-06	1.79e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—thyroid cancer	1.76e-06	1.71e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—thyroid cancer	1.72e-06	1.67e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—thyroid cancer	1.62e-06	1.57e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—thyroid cancer	1.61e-06	1.56e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—thyroid cancer	1.06e-06	1.03e-05	CbGpPWpGaD
